Form 8-K - Current report:
SEC Accession No. 0001193125-20-081621
Filing Date
2020-03-23
Accepted
2020-03-23 08:32:13
Documents
12
Period of Report
2020-03-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d895385d8k.htm   iXBRL 8-K 38067
  Complete submission text file 0001193125-20-081621.txt   161701

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrna-20200323.xsd EX-101.SCH 3073
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrna-20200323_lab.xml EX-101.LAB 17374
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrna-20200323_pre.xml EX-101.PRE 10955
8 EXTRACTED XBRL INSTANCE DOCUMENT d895385d8k_htm.xml XML 3228
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 20733762
SIC: 2836 Biological Products, (No Diagnostic Substances)